Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hepatitis C, Chronic D019698 12 associated lipids
Coronary Stenosis D023921 6 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Encephalitis D004660 15 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Contracture D003286 3 associated lipids
Stomatitis D013280 14 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Noguchi K et al. The detection of platelet-activating factor in inflamed human gingival tissue. 1989 Arch. Oral Biol. pmid:2783040
Agwu DE et al. Mass determination of receptor-mediated accumulation of phosphatidate and diglycerides in human neutrophils measured by Coomassie blue staining and densitometry. 1989 Biochem. Biophys. Res. Commun. pmid:2466463
Wainwright CL et al. The effects of PAF antagonists on arrhythmias and platelets during acute myocardial ischaemia and reperfusion. 1989 Eur. Heart J. pmid:2468494
Lippe IT and Holzer P The diacylglycerol kinase inhibitor, R 59022, suppresses contractility of intestinal smooth muscle. 1989 Eur. J. Pharmacol. pmid:2468509
Etienne A et al. Modulation by drugs of eosinophil recruitment induced by immune challenge in the rat. Possible roles of interleukin 5 and platelet-activating factor. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468617
Cirino G et al. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. 1989 Proc. Natl. Acad. Sci. U.S.A. pmid:2470103
Bregestovski PD and Ryan US Voltage-gated and receptor-mediated ionic currents in the membrane of endothelial cells. 1989 J. Mol. Cell. Cardiol. pmid:2471836
Slattery CW and Beaumont DO Sheep platelets as a model for human platelets: evidence for specific PAF (platelet activating factor) receptors. 1989 Thromb. Res. pmid:2554526
Kester M et al. Beta-adrenergic inhibition of AGEPC-stimulated Na+/Ca2+ exchange and AGEPC-induced platelet activation. 1989 Biochim. Biophys. Acta pmid:2554977
Korth R et al. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells. 1989 Br. J. Pharmacol. pmid:2555017
Chao W et al. Regulation of platelet-activating factor receptors in rat Kupffer cells. 1989 J. Biol. Chem. pmid:2555359
Travers JB et al. Identification of functional platelet-activating factor receptors in Raji lymphoblasts. 1989 J. Immunol. pmid:2555416
Hosford D et al. Platelet-activating factor and cytokine interactions in shock. 1989 Resuscitation pmid:2555874
Muirhead EE et al. Biologic contrasts between medullipin I and vasoactive glyceryl compounds. 1989 Am. J. Med. Sci. pmid:2764021
Stengel PW and Silbaugh SA Reversal of A23187-induced airway constriction in the guinea pig. 1989 J. Pharmacol. Exp. Ther. pmid:2495351
Wey HE Phorbol diester enhances calcium ionophore A23187-induced [3H]acetate incorporation into platelet-activating factor in murine macrophages: predominant incorporation into 1-O-acyl-2-acetyl-sn-glycero-3-phosphocholine. 1989 J. Cell. Biochem. pmid:2496135
Stewart AG et al. Evidence for an intracellular action of platelet-activating factor in bovine cultured aortic endothelial cells. 1989 Br. J. Pharmacol. pmid:2497920
Cucala M et al. Central regulation of gastric acid secretion by platelet-activating factor in anesthesized rats. 1989 Prostaglandins pmid:2499013
Lomazova KD et al. [The thrombocyte-activation factor and endotoxin-induced thrombocyte activation]. 1989 Biull Eksp Biol Med pmid:2500157
Kajiyama Y et al. Pertussis toxin-sensitive GTP-binding proteins may regulate phospholipase A2 in response to thrombin in rabbit platelets. 1989 Arch. Biochem. Biophys. pmid:2505676
Yeo YK et al. The effect of long-term consumption of fish oil on platelet-activating factor synthesis in rat renal microsomes. 1989 Biochem. Biophys. Res. Commun. pmid:2543394
Nakashima S et al. Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils. 1989 J. Immunol. pmid:2545786
Warren JS et al. Evidence for the role of platelet-activating factor in immune complex vasculitis in the rat. 1989 J. Clin. Invest. pmid:2536403
Kurihara K et al. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021. 1989 J. Allergy Clin. Immunol. pmid:2536413
Hwang SB et al. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors. 1989 Mol. Pharmacol. pmid:2536468
Bazill GW and Dexter TM An antagonist to platelet activating factor counteracts the tumoricidal action of alkyl lysophospholipids. 1989 Biochem. Pharmacol. pmid:2536543
Barzaghi G and Mong S Platelet activating factor-amidophosphonate (PAF-AP), a partial agonist inhibited platelet activating factor-induced calcium mobilization in human monocytic leukemic U-937 cell. 1989 Life Sci. pmid:2536882
Schlondorff D Interactions of platelet activating factor and prostaglandins in the glomerulus and in mesangial cells. 1989 Adv. Exp. Med. Biol. pmid:2696352
Snyder F Biochemistry of platelet-activating factor: a unique class of biologically active phospholipids. 1989 Proc. Soc. Exp. Biol. Med. pmid:2536942
Remuzzi G Eicosanoids and platelet activating factor as possible mediators of injury in experimental nephropathies. 1989 Adv. Exp. Med. Biol. pmid:2696353
Henson PM PAF--a perspective. 1989 Am. J. Respir. Cell Mol. Biol. pmid:2696514
Bernardini R et al. The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary-adrenal axis in the rat. 1989 Endocrinology pmid:2546734
Pirotzky E et al. Involvement of platelet-activating factor in renal processes. 1989 Adv. Lipid Res. pmid:2698054
Snyder F et al. Platelet-activating factor and related ether lipid mediators. Biological activities, metabolism, and regulation. 1989 Ann. N. Y. Acad. Sci. pmid:2698076
Okubo K et al. The existence of a platelet-activating factor (Paf-acether)-like substance in blister fluid derived from patients with bullous pemphigoid as demonstrated by human platelet aggregation techniques. 1989 Kurume Med J pmid:2700767
Johnson RA et al. An asymmetric synthesis of (R) and (S)-1-alkoxy-2,3-propanediols including precursors to platelet activating factor. 1989 Chem. Phys. Lipids pmid:2766428
Tanizawa H and Tai HH Synergism between chemotactic peptide and platelet-activating factor in stimulating thromboxane B2 and leukotriene B4 biosynthesis in human neutrophils. 1989 Biochem. Pharmacol. pmid:2547385
O'Flaherty JT et al. Bidirectional effects of protein kinase C activators. Studies with human neutrophils and platelet-activating factor. 1989 J. Biol. Chem. pmid:2540163
Pritze S et al. Effect of platelet-activating factor (PAF) on porcine pulmonary vessels in vitro. 1989 Prog. Clin. Biol. Res. pmid:2798458
Dembinska-Kiec A et al. Release of cysteinyl leukotrienes is of minor importance in platelet-activating factor-induced reduction of perfusion rate in the rat gastric vascular bed. 1989 Prog. Clin. Biol. Res. pmid:2798459
dos Santos OF et al. Effect of platelet-activating factor antagonist on cyclosporine nephrotoxicity. Glomerular hemodynamics evaluation. 1989 Transplantation pmid:2705209
Neuwirth R et al. Extra- and intracellular metabolism of platelet-activating factor by cultured mesangial cells. 1989 Am. J. Physiol. pmid:2705543
Stewart AG and Phillips WA Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages. 1989 Br. J. Pharmacol. pmid:2553184
Christman BW and Blair IA Analysis of platelet activating factor in human saliva by gas chromatography/mass spectrometry. 1989 Biomed. Environ. Mass Spectrom. pmid:2706378
Varol FG et al. Platelet-activating factor stimulates phosphatidylinositol hydrolysis in the rat myometrium. 1989 Eur. J. Pharmacol. pmid:2707303
Harper MJ et al. Spermicidal effect of antagonists of platelet-activating factor. 1989 Fertil. Steril. pmid:2707465
Danyoshi C et al. Pyrrolidine derivatives as inhibitors of platelet aggregation induced by platelet activating factor. 1989 Chem. Pharm. Bull. pmid:2805179
Macpherson JL et al. Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis. 1989 Clin. Exp. Immunol. pmid:2805409
McCormack DG et al. Evidence against a role for platelet-activating factor in hypoxic pulmonary vasoconstriction in the rat. 1989 Clin. Sci. pmid:2805602
Avdonin PV et al. Selective inactivation by endogenous protein kinase C of human platelet high-affinity GTPase coupled with PAF receptors. 1989 J. Mol. Cell. Cardiol. pmid:2543823
Salem P et al. Presence of paf-acether in human thymus. 1989 FEBS Lett. pmid:2806565
Ryan US Endothelium as a transducing surface. 1989 J. Mol. Cell. Cardiol. pmid:2543830
Straube W [Early embryonal signals]. 1989 Zentralbl Gynakol pmid:2665388
Carveth HJ et al. Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. 1989 Biochem. Biophys. Res. Commun. pmid:2665743
Sánchez Crespo M Biosynthesis of platelet-activating factor: the role of the remodeling pathway. 1989 Methods Find Exp Clin Pharmacol pmid:2666805
Kaminker AJ and Carreras LO [Physiopathology of thrombotic microangiopathy]. 1989 Sangre (Barc) pmid:2667170
Abisogun AO et al. The involvement of platelet activating factor in ovulation. 1989 Science pmid:2911750
Benedetto C et al. Reduced serum inhibition of platelet-activating factor activity in preeclampsia. 1989 Am. J. Obstet. Gynecol. pmid:2912073
Bazill GW and Dexter TM Platelet activating factor antagonist L-652,731 inhibits thymidine transport. 1989 Biochem. Pharmacol. pmid:2914023
Petty AC and Scrutton MC Platelet aggregation in whole blood: is the response to adrenaline, 5-hydroxytryptamine and PAF a direct consequence of stimulation by these agonists? 1989 Thromb. Res. pmid:2749609
VornovitskiÄ­ EG et al. [Cardiodepressive effect of platelet activating factor]. 1989 Biull Eksp Biol Med pmid:2914168
Gallin EK Evidence for a Ca-activated inwardly rectifying K channel in human macrophages. 1989 Am. J. Physiol. pmid:2750892
Palmantier R et al. Biosynthesis of paf-acether. XIV. Paf-acether output in murine peritoneal macrophages is regulated by the level of acetylhydrolase. 1989 Biochem. Biophys. Res. Commun. pmid:2751666
Ontell SJ et al. Pharmacologic modulation of experimental postischemic hepatic function. 1989 Ann. Surg. pmid:2916864
Gelas P et al. Differential activation by fMet-Leu-Phe and phorbol ester of a plasma membrane phosphatidylcholine-specific phospholipase D in human neutrophil. 1989 FEBS Lett. pmid:2753160
Filep J et al. Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog. 1989 Biochem. Biophys. Res. Commun. pmid:2916986
Tilley JW et al. Biphenylcarboxamide derivatives as antagonists of platelet-activating factor. 1989 J. Med. Chem. pmid:2754708
Braquet P et al. Role of cytokines and platelet-activating factor in microvascular immune injury. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2651321
Lee TH Pharmacological modulation of leukotriene and platelet activating factor biosynthesis and activities by alternative dietary fatty acids. 1989 Clin. Exp. Allergy pmid:2653575
Straube W [Which signals of early pregnancy are known currently, what cer- tainty have they and exactly how far are they applicable in practice?]. 1989 Zentralbl Gynakol pmid:2655355
Takayasu M et al. Endothelin-induced mobilization of Ca2+ and the possible involvement of platelet activating factor and thromboxane A2. 1989 Biochem. Biophys. Res. Commun. pmid:2655596
Pretolani M et al. From anti-asthma drugs to PAF-acether antagonism and back. Present status. 1989 Biochem. Pharmacol. pmid:2655601
Esplugues JV and Whittle BJ Gastric effects of PAF. 1989 Methods Find Exp Clin Pharmacol pmid:2657290
Lister MD et al. Inhibition studies on the membrane-associated phospholipase A2 in vitro and prostaglandin E2 production in vivo of the macrophage-like P388D1 cell. Effects of manoalide, 7,7-dimethyl-5,8-eicosadienoic acid, and p-bromophenacyl bromide. 1989 J. Biol. Chem. pmid:2498315
Leonelli FM et al. Plasma levels of the lyso-derivative of platelet-activating factor in acute severe systemic illness. 1989 Clin. Sci. pmid:2582728
Spina D et al. The role of platelet activating factor in allergic inflammation. 1989 Pulm Pharmacol pmid:2520484
Rylander R Role of endotoxin and glucan for the development of granulomatous disease in the lung. 1989 Sarcoidosis pmid:2623374
Buckley TL and Hoult JR Platelet activating factor is a potent colonic secretagogue with actions independent of specific PAF receptors. 1989 Eur. J. Pharmacol. pmid:2542064
Teles de Araújo A et al. Surfactant modifications and lipidic mediators in occupational lung diseases. 1989 Sarcoidosis pmid:2623375
Tomioka K et al. YM461, a PAF antagonist, blocks antigen-induced late airway responses and airway hyperresponsiveness in allergic sheep. 1989 Eur. J. Pharmacol. pmid:2620695
Benfenati E et al. Development of a mass spectrometric method to quantitate platelet activating factor in mouse urine. 1989 J. Lipid Res. pmid:2621424
Sueoka K et al. In-vivo and in-vitro determination of components of rabbit early pregnancy factors. 1989 J. Reprod. Fertil. pmid:2621714
Marx MH et al. Darmstoff analogues. 3. Actions of choline esters of acetal phosphatidic acids on visceral smooth muscle. 1989 J. Med. Chem. pmid:2724301
Fitzgerald MF et al. Release of PAF-acether and eicosanoids from guinea-pig alveolar macrophages by FMLP: effect of cyclo-oxygenase and lipoxygenase inhibition. 1989 Eur. J. Pharmacol. pmid:2548873
Tou JS Platelet-activating factor regulates phospholipid metabolism in human neutrophils. 1989 Lipids pmid:2586238
Bradley LM et al. Influence of thromboxane A2 receptor antagonism on pulmonary vasoconstrictor responses. 1989 Pediatr. Res. pmid:2587116
Yanagihara Y et al. Immunopharmacological studies on TBX, a new antiallergic drug (3). Inhibitory effects on histamine release from lung fragments and bronchoconstriction in guinea pigs. 1989 Jpn. J. Pharmacol. pmid:2478743
Smith D et al. The effect of prophylactic anti-asthma drugs on PAF-induced platelet accumulation in the thorax of the guinea pig. 1989 Jpn. J. Pharmacol. pmid:2593374
Sanjar S et al. Inhibition of PAF-induced eosinophil accumulation in pulmonary airways of guinea pigs by anti-asthma drugs. 1989 Jpn. J. Pharmacol. pmid:2593375
Iwai A et al. Role of PAF in ischemia-reperfusion injury in the rat stomach. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595310
Binnaka T et al. Gastric mucosal damage induced in rats by intravenous administration of platelet-activating factor. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595311
Kitagawa S et al. Inhibitory effects of phenol derivatives on bovine platelet aggregation and their effects on Ca2+ mobilization. 1989 Biochim. Biophys. Acta pmid:2493810
Mózes T et al. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock. 1989 Am. J. Physiol. pmid:2802004
Saxena SP et al. Histamine formed in stimulated human platelets is cytoplasmic. 1989 Biochem. Biophys. Res. Commun. pmid:2803292
Ormerod AD et al. Effects of alprazolam on platelet activating factor-induced wealing. 1989 Br. J. Dermatol. pmid:2803963
PAF antagonists in asthma. 1989 Lancet pmid:2564116
Randriamampita C and Trautmann A Biphasic increase in intracellular calcium induced by platelet-activating factor in macrophages. 1989 FEBS Lett. pmid:2544447
Uhl D [Platelet activating factor and platelet activating factor antagonists. New methods in asthma therapy?]. 1989 Med Monatsschr Pharm pmid:2544789
Chau LY et al. Photoaffinity labeling of platelet activating factor binding sites in rabbit platelet membranes. 1989 Biochem. Biophys. Res. Commun. pmid:2545193
Ichikawa Y et al. [Effect of glycyrrhizin on the production of platelet-activating factor from rat peritoneal exudate cells]. 1989 Arerugi pmid:2783037